BlueRock Therapeutics Competitors and Similar CompaniesClear all
BlueRock Therapeutics's competitors and similar companies include ACADIA Pharmaceuticals, Sangamo Therapeutics, Regenxbio and Froceth.
 ACADIA Pharmaceuticals ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders. |  Sangamo Therapeutics Sangamo Therapeutics (formerly known as Sangamo BioSciences) is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of engineered DNA-binding proteins for the development of novel therapeutic strategies. |  Regenxbio Regenxbio is a clinical-stage biotechnology company providing gene therapy product candidates for the treatment of retinal, metabolic, and neurodegenerative diseases. |  Froceth Froceth is a biotechnology company manufacturing advanced therapy medicinal products (ATMPs). | ||
Founding Date | Founding Date 2016 | Founding Date 1993 | Founding Date 1995 | Founding Date 2009 | Founding Date 2014 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Cambridge, US HQ Toronto, CA Berlin, DE New York, US | Locations San Diego, US HQ Princeton, US | Locations Brisbane, US HQ Nice Area, FR Cheltenham, GB London, GB Richmond, US | Locations Rockville, US HQ | Locations Vilnius, LT HQ |
Employees | Employees 477 | Employees 513 | Employees 35417% increase | Employees 4018% increase | Employees 7 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 2.4 b | Valuation ($) 416.4 m | Valuation ($) 447.8 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $1.1b (FY, 2025) | Revenue (est.) $39.6m (FY, 2025) | Revenue (est.) $170.4m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income N/A | Net income $391m (FY, 2025) | Net income ($122.9m) (FY, 2025) | Net income ($193.9m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 225m | Total funding raised $ 770.8m | Total funding raised $ 74.2m | Total funding raised $ 118.9m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
ACADIA Pharmaceuticals
HQ
San Diego, US
Employees
513
ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders.
View companySangamo Therapeutics
HQ
Brisbane, US
Employees
354↑ 17% increase
Sangamo Therapeutics (formerly known as Sangamo BioSciences) is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of engineered DNA-binding proteins for the development of novel therapeutic strategies.
View companyRegenxbio
HQ
Rockville, US
Employees
401↑ 8% increase
Regenxbio is a clinical-stage biotechnology company providing gene therapy product candidates for the treatment of retinal, metabolic, and neurodegenerative diseases.
View companyFroceth
HQ
Vilnius, LT
Employees
7
Froceth is a biotechnology company manufacturing advanced therapy medicinal products (ATMPs).
View company